Breckenridge announced the launch of Duloxetine Delayed-Release Capsules, the generic version of Eli Lilly’s Cymbalta.

Cymbalta is currently approved for the treatment of generalized anxiety disorder, fibromyalgia, major depressive disorder, chronic musculoskeletal pain (eg, low back pain, osteoarthritis pain), and diabetic peripheral neuropathic pain. Although the exact mechanisms of Cymbalta are unknown, they are believed to be related to the potentiation of serotonergic and noradrenergic activity in the CNS.

RELATED: FDA Approves First Generic Versions of Cymbalta

Duloxetine Delayed-Release Capsules are available in 20mg, 30mg, and 60mg strengths.

For more information call (561) 443-3314 or visit